"Syngenta will remain Syngenta"

At the Annual General Meeting of Syngenta AG held on April 26, 2016, the 1337 shareholders representing 50.68% of the total shares approved all the motions proposed by the Board of Directors.

The shareholders approved motions including an ordinary dividend of CHF 11.00 per share and a special dividend of CHF 5.00 per share, the latter contingent upon the public tender offer by CNAC Saturn (NL) B.V., an indirect subsidiary of China National Chemical Corporation, becoming unconditional.

All members of the Board of Directors were re-elected for a term of one year, with the exception of Jacques Vincent, who has reached the statutory age limit and is retiring. Michel Demaré was re-elected as Chairman of the Board of Directors.

In his speech Michel Demaré commented on the ChemChina offer: “I firmly believe that this is a transaction truly in the interests of all stakeholders. First of all, Syngenta will remain Syngenta. We will continue to be headquartered in Basel and be a science-based company focused on innovation. We will maintain the highest standards of corporate governance, ethics and reporting, and we will have an owner that will invest in the business with a long-term vision, providing us with the stability required for a company with such a long investment horizon. We will therefore be in an excellent position to offer growers continued choice for many years ahead.”

“The price of $465 per share plus a special dividend of 5 Swiss francs reflects not just past performance, but also some of the future potential of the company and is thus full and fair. The Board recommends that you tender your shares in the offer, which opened on March 23, 2016.”

For more information:
www.agm-2016.syngenta.com